Nonerosive gastroesophageal reflux disease
Conditions
Interventions
The treatment group:Hewei Jiangni Decoction + dummy omeprazole
The control group:dummy Hewei Jiangni Decoction granules + omeprazole
Sponsors
Dongfang Hospital of Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) patients who met the diagnostic criteria of Western medicine; (2) aged 18-65 years; (3) not receiving acid-inhibitory drugs or gastric mucosal protective agents within 2 weeks; (4) exclude other gastrointestinal diseases by gastroscopy to confirm NERD; (5) voluntarily participated in this study, written informed consent.
Exclusion criteria
Exclusion criteria: (1) patients with reflux esophagitis, reflux hypersensitivity and Barrett's esophagus; (2) patients with a history of upper gastrointestinal bleeding or surgery, esophageal stenosis, esophageal and gastric tumors, and other organic lesions; (3) patients with cardiovascular and cerebrovascular diseases, liver, kidney and hematopoietic system and other serious primary diseases; (4) lactating and pregnant women; (5) patients with a history of mental or neurological disorders or those who are difficult to complete; (6) patients currently participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GERD - Q scale integral;TCM syndrome scale integral;SF36 scale integral;PRO scale integral; | — |
Countries
China
Contacts
Public ContactChune Xie
Outcome results
None listed